Status:
COMPLETED
Effect of eHealth Encouragements to Intensive Exercise in Adolescents With Congenital Heart Disease
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Congenital Heart Disease
Eligibility:
All Genders
13-16 years
Phase:
PHASE2
Brief Summary
All over the world 0.8 % of all live children are born with a Congenital Heart Disease (CHD) due to genetic end environmental causes. Advanced treatment and care has enhanced survival substantially, a...
Eligibility Criteria
Inclusion
- Congenital heart disease with allowance for unrestricted exercise
- Diagnosis: Q20.0 Truncus arteriosus communis, Q20.1 Transpositio vasorum incompleta, Q20.3 Transpositio vasorum completa, Q20.5 Inversio ventriculorum cordis, Q21.2 Defectus septi atrioventriculorum cordis, Q21.3 Tetralogia Steno-Fallot, Q22.4 Tricusspidalatresia , Q22.5 Anomalia Ebstein, Q23.2 Mitralatresia, Double outlet right ventricle, Q23.3 Hypoplasia ventriculi sinistri cordis syndrome, Q23.3 Hypoplasia ventriculi dextrii cordis syndrome, Q24.4 Stenosis subaortae congenita, Q25.1 Coarctatio aortae, Q25.1 Coarctatio Aortae, Double inlet left ventricle, Q25.3 Stenosis aortae supravalvularis, Q25.5 Pulmonalatresia.
- Successful Total Cavo Pulmonal Connex (TCPC procedure)
- 13- 16 years of age
Exclusion
- Mental retardation
- Untreated asthma
- Syndromes related to CHD
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2014
Estimated Enrollment :
158 Patients enrolled
Trial Details
Trial ID
NCT01189981
Start Date
October 1 2010
End Date
May 1 2014
Last Update
October 1 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Copenhagen
Copenhagen, RegionH, Denmark, 2100